Medtronic EndurAnt Stent Graft system vs ExcluDer endoprothesis: a global, prospectiVe, rANdomized Clinical trial in sac rEgression (ADVANCE Study),
Role: Investigator,
Medtronic, Inc.,
(12/2024 - 12/2025)
Status: Approved
Clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) Protocol Number: EFC4505 dated 13 June 2002; includes Clinical Investigator's Brochure Edition 07 dated 22 March 2002, Patient Information Card, and IND Safety Reports.,
Role: Investigator,
Sanofi-Synthelabo Pharmaceuticals,
(12/2004 - 12/2005)
Status: Completed